Our robots are making sure that 'too expensive' and 'not enough' no longer stand between a patient and their cure.
The next generation of biological drugs is showing incredible promise in terms of safety and efficacy. The science is working. But the manufacturing stack, built decades ago for small molecules and large batches, was never designed for the complexity, precision, and throughput that advanced therapies now demand. What worked for the last generation of pharma can't work for the next.
Through imitiation learning, parallel orchestration, and real-time monitoring, our robots enable your existing instrument ecosystem to scale. When demand doubles, deploy another cluster, scaling throughput without increasing process complexity.
Explore the PlatformThe Cluster connects your existing GMP instruments inside a closed, automated environment. Your process stays the same. Your throughput increases by up to 100x, and costs decrease by 74%.






Biologics manufacturing is made up of dozens of discrete unit operations, each one requiring a highly controlled, closed sterile environment and strong repeatability across every transfer, every dispense, every interaction. Multiply Labs automates the entire sequence inside a closed, GMP-ready system.
Each operation is orchestrated by robotic arms operating in sterile environments, significantly reducing contamination risk, and executing with precision run after run.
Multiply Labs' software enables your manufacturing protocol to be robotically executed, collecting every sensor reading and every interaction in real time. We deliver complete electronic records directly to you and your quality system.
Physical AI and robotics now make reliable closed-loop biomanufacturing economically viable. We build the technology that enables you to get there first.
Roboticists, scientists, and engineers building the robotic future of biomanufacturing.
Schedule a visit to our facility in San Francisco and see the robotic manufacturing platform with your own eyes.